(Hardiman et al., 2017) Numerous transgenic mouse models mimicking ALS symptoms have been developed over the past 25 years (for Review see (Hardiman et al., 2017)), with the SOD1 mouse model remaining the workhorse for evaluating basic mechanisms of neurodegeneration and therapeutic strategies. This evidence concerns the gene SOD1 and amyotrophic lateral sclerosis.